Standalone figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 | 24 | 24 | 32 | 38 | 40 | 40 | 46 | 47 | 35 | 42 | 48 | |
| COGS | 11 | 11 | 13 | 17 | 19 | 20 | 19 | 25 | 24 | 14 | 23 | 28 |
| Gross profit | 12 | 12 | 11 | 14 | 19 | 20 | 21 | 21 | 23 | 21 | 19 | 20 |
| 7 | 8 | 7 | 8 | 12 | 13 | 13 | 15 | 16 | 15 | 12 | 14 | |
| 5 | 4 | 4 | 6 | 6 | 7 | 7 | 6 | 7 | 6 | 7 | 7 | |
| OPM % | 21.4% | 16.7% | 14.8% | 18.8% | 17.1% | 16.5% | 18.5% | 13.7% | 14.7% | 17% | 16.6% | 14.2% |
| Depreciation | 2 | 1 | 1 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 2 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 1 |
| 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | |
| Profit before tax | 2 | 3 | 2 | 3 | 3 | 4 | 3 | 2 | 3 | 2 | 3 | 3 |
| Tax | 1 | 0 | -0 | -0 | -0 | -0 | 0 | 1 | 1 | -0 | -0 | 0 |
| Tax % | 50.2% | 7.6% | -6.7% | -0.7% | -13.1% | -1.8% | 4.6% | 39.1% | 21.5% | -1% | -2.3% | 13.9% |
| 1 | 2 | 3 | 3 | 3 | 4 | 3 | 1 | 2 | 2 | 3 | 3 | |
| PAT margin % | 5% | 9.7% | 10.7% | 9.7% | 9.2% | 10% | 8.4% | 2.6% | 4.7% | 5.8% | 6.5% | 5.5% |
| EPS (₹) | 0.8 | 1.6 | 1.7 | 2 | 2.2 | 2.6 | 2.1 | 0.8 | 1.4 | 1.3 | 1.7 | 1.7 |
| Results filing | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +3.1% | +9% | -1.4% | +40.2% | +60.4% | +69.2% | +66.3% | +46.5% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Agrochemicals | 43.83 | 6.31 | 312.73 | 58.41 | 254.32 |
| Unallocated other operating revenue | 2.44 | 0 | 0 | 0 | — |
| +23.8% |
| -12.5% |
| +6% |
| +4.7% |
| PAT YoY % | -71% | -20.1% | -22.7% | +21.3% | +194.9% | +74% | +30.1% | -60.3% | -36.5% | -49.5% | -18% | +118% |
| Active Pharma Ingredient (API) | 2.18 | -1.98 | 125.57 | 14.48 | 111.09 |
| Pharma Formulations | 0 | 0 | 0 | 0 | — |
₹ crore by quarter